SIMEGUT OS GTT FL 30ML

SIMEGUT BAMBINI GOCCE ORALI, EMULSION

active ingredients

1 ml of emulsion contains: Active Ingredient, Symeticons 66,6 mg For full list of excipients, see 6.1.

Excellent

Hydroxypropylcellulose, carbopol, p-hydroxybenzoate methyl, p-hydroxybenzoate propile, citric acid, banana essence, purified water.

Therapeutic indications

Syntomatic treatment of gastro-enteric meteorism and infant aerophagia.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients. Generally contraindicated in pregnancy (see paragraph 4.6).

Population

Milking and children: 20 drops (= 0.6 ml) 2-4 times a day preferably after meals, or otherwise according to prescription. Shake well before use. The drops must be dispersed in little water.

Conservation

Store in the original container to keep it safe from the light.

Warnings

The drops contain para-hydroxybenzoates that can cause allergic reactions (also delayed type). Do not exceed the recommended doses. After a short period of treatment (7 days) without appreciable results consult your doctor.

Interactions

They are not known, nor have they been reported, interactions with other drugs.

Effects

Undesirable effects due to Simegut have not been highlighted.

Overdosing

Overdose phenomena have not been reported with the use of Simegut.

Pregnancy: There is no adequate data on the use of Simegut in pregnant women, so it should not be used in pregnancy unless a real need and after risk/benefit assessment by the doctor. Nursing: It is not known whether symeticons are excreted in breast milk. The excretion of symeticons in breast milk was not studied in animals. The decision whether to continue/interrupt breastfeeding or continue/interrupts semeticon therapy should be taken taking into consideration the benefit of breastfeeding for the newborn and the treatment based on symeticons for the woman.

Source: Farmadati